BACKGROUND: In regions such as Hong Kong, rapid economic development has led to lifestyle alterations characterized by increases in energy and fat intake and reduction in physical activity. These changes have been associated with a dramatic increase in the prevalence of diabetes and related diseases of the metabolic syndrome. OBJECTIVE: To investigate if a common polymorphism (Trp64Arg) of the b b 3 -adrenergic receptor gene, previously implicated as predisposing to type 2 diabetes mellitus or obesity in other populations, has a role in the apparent susceptibility of Hong Kong Chinese to diabetes and related disorders. METHOD: A PCR-based protocol was used to genotype 802 Southern Chinese subjects who were either healthy or had one or more of the metabolic disorders including diabetes, hypertension or dyslipidaemia. RESULTS: The frequencies of the mutant A allele (12.7%) and AA genotype (1.7%) did not differ, by the w w 2 test, in any patient group with diabetes, hypertension or dyslipidaemia, alone or in combination, compared to healthy controls. Using the t-test in the 802 subjects, those carrying the mutant A allele had evidence of increased obesity with a signi®cantly (all P`0.05) higher body mass index (BMI, kgam 2 ) and also lower HDL-cholesterol. BMI was also elevated in subjects with the A allele in the separate groups with diabetes, dyslipidaemia or hypertension. Stepwise multiple regression showed this polymorphism to be an independent predictor of BMI. CONCLUSION: These data do not support any direct involvement of the Trp64Arg polymorphism in the development of diabetes, hypertension or dyslipidaemia in Chinese subjects, but do suggest a relationship with obesity.
Introduction
The clustering of type 2 diabetes mellitus, dyslipidaemia and hypertension is often referred to as the metabolic syndrome. 1, 2 Obesity, and in particular visceral obesity, appears to be an important link between these disorders. 2, 3 Visceral fat is metabolically more active than subcutaneous fat and associated with insulin resistance. 3, 4 Compared with subcutaneous fat, lipolysis in visceral fat is more sensitive to catecholamine stimulation, but less to insulin inhibition. 3, 4 The systems regulating body fat depots and energy homeostasis are complex. Generally, body weight and fat stores are maintained within a narrow range for many years, despite wide ranging levels of energy intake and physical activity. 5 In rodents, an important mechanism for maintaining constant body weight in this dynamic process involves catecholamine-stimulated thermogenesis in brown adipose tissue and skeletal muscle. 5 The b 3 -adrenergic receptor is the principle mediator of catecholamine-stimulated thermogenesis in brown adipose tissue and lipolysis in white adipose tissue, which occur at both subcutaneous and visceral sites. 6 In humans, brown fat is dispersed amongst the white adipose tissue and is not readily isolated. 6 Human immortalized brown adipocytes express functional b 3 -adrenergic receptors coupled to lipolysis. 7 A common polymorphism has been found in the human b 3 -adrenergic receptor gene that involves the change of tryptophan at position 64 to arginine, which is the amino acid found in most other mammalian species. This mutation has been associated with hyperinsulinaemia or features of insulin resistance. 8, 9 In some studies, this mutation has been shown to be associated with type 2 diabetes 10 or its early onset, 8, 11, 12 as well as with phenotypes related to obesity. 8,9,13 ± 15 However, negative studies have also been reported for the above diabetes and obesity-related parameters. 16 ± 18 Considering the limited strength of the positive associations and the number of negative associations, the functional importance of this mutation has been questioned. 19 However, other groups disagree, proposing that this polymorphism may be a weak metabolic modulator, which is only one of several genetic parameters that contribute to obesity or insulin resistance. 16, 20, 21 Increasing Westernization in Hong Kong, with associated high fat and calorie diets and low levels of physical activity, has led to dramatic increases in the prevalence of the components of the metabolic syndrome, particularly type 2 diabetes. 22 Therefore, understanding the genetic and envrionmental parameters that contribute to the metabolic sydrome may lead to earlier identi®cation of subjects at risk and to more effective interventions to prevent the development or progression of the associated cardiovascular and renal complications. There is only one study and none in the English language of the b 3 -adrenergic receptor polymorphism in Chinese populations and, furthermore most of the previous studies of this polymorphism in populations of different ethnicity involved only one group of patients, such as those with type 2 diabetes. We believe this is the ®rst study to report data on the involvement of the b 3 -adrenergic receptor gene in a large group of subjects exhibiting different components of the metabolic syndrome.
Methods
The study protocol was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong. All 802 unrelated subjects gave written informed consent. They were of Southern Han Chinese origin, without any known ancestors of other ethnic origin, and were living in the Hong Kong Special Administrative Region of China at the time of the study. The catchment area of the Prince of Wales Hospital has only developed since the 1960s, and serves a population of over 1 million. The majority of its inhabitants are a typical socio-economic representation of ®rst or second-generation migrants from Southern China now living in a Westernized environment.
Subjects were recruited from the hypertension or diabetes clinics at the Prince of Wales Hospital. Seated blood pressure, presented as mean arterial pressure, and plasma biochemical parameters measured after an overnight fast, as well as the anthropometric parameters required to calculate the body mass index (BMI) and waist-to-hip ratio (WHR) were documented. Subjects with impaired fasting glucose and diabetes were diagnosed based on fasting plasma glucose (FPG) concentrations. An FPG`6.0 mmolal was taken as normal glucose tolerance, an FPG of 6.0 ± 7.0 mmolal was considered to be impaired fasting glucose (IFG) and ! 7.0 mmolal was indicative of diabetes. 23 If the subject had no diabetes-related complaints, then two elevated FPG readings were required for diagnosis; but, if the subject was symptomatic, a single elevated reading suf®ced. Subjects with equivocal plasma glucose values underwent a 75 g oral glucose tolerance test and a 2 h post-glucose loading value of 7.8 ± 11.1 mmolal was de®ned as impaired glucose tolerance. 23 In this study, subjects with IFG or glucose intolerance and type 2 diabetes were grouped together and considered to have glucose intolerance (GIT) and 81.1% of these GIT subjects had type 2 diabetes.
Subjects were de®ned as hypertensive, if, after 5 min rest, their seated systolic blood pressure (SBP) was ! 140 mmHg andaor diastolic blood pressure (DBP) ! 90 mmHg on at least two occasions whilst off antihypertensive treatment (after a 4 week washout period). 24 A mean of three readings taken 1 min apart was used. No subjects had a history of signi®cant renal, hepatic or cardiac disease or eating disorders. Normotensive (SBP was`140 mmHg and DBP was`90 mmHg) non-diabetic (FPG`6.0 mmolal) controls were recruited from the hospital staff and their friends.
Obesity was de®ned dichotomously as a BMI of ! 25.0 kgam 2 or ! 27.0 kgam 2 or WHR ! 0.85 or ! 0.90 for females and males, respectively. 23 Dyslipidaemia was classi®ed as either a fasting plasma total cholesterol ! 6.2 mmolal or between 5.2 and 6.2 mmolal with the total cholesterol to HDL-cholesterol ratio being ! 5.0, andaor fasting plasma triglycerides ! 2.3 mmolal. 25, 26 The subjects were classi®ed as controls or into seven non-overlapping groups based on whether they had one of the three conditions of GIT, hypertension or dyslipidaemia alone or in the various possible combinations (Table 2) . Additionally, overlapping groups of subjects, classi®ed as having GIT, hypertension, dyslipidaemia or obesity according to the above criteria, but containing subjects with varying degrees of the other parameters were also analysed. Due to the various types of metabolic derangement occurring together in the same patient, the combined numbers of subjects in these groups exceeds 802.
The amino acid 64 transition Tryptophan to arginine (Trp ± Arg) was identi®ed using a PCR-based RFLP method with BstOI digestion. 8 Two investigators read the gels independently and were blind to the phenotype of the subjects.
Statistical analyses
Data concerning normally distributed parameters are presented as mean AE s.d. whereas skewed data were logarithmically transformed and expressed as geometric mean with 95% con®dence intervals. Differences in the biochemical and anthropometric markers between groups were compared using Student's t-test. When the t-test identi®ed differences between the subjects carrying the A allele (heterozygotes plus homozygotes) compared to those with only the T b b 3 -adrenergic receptor polymorphism and obesity GN Thomas et al allele, the relationship between the three individual genotypes was investigated by analysis of variance. Those relationships that appeared linear between the genotypes and the anthropometric parameters were assessed by partial correlation analysis that included age and gender as covariates. The Statistics Package for Social Sciences (SPSS for windows, version 7.5.1, SPSS Inc.) was used for the analyses. Differences in the genotype and allele frequencies between the control and the affected populations and between tertiles of increasing BMI in the entire population were analysed using the w 2 test and odds ratios (EpiInfo version 5.0, Statcalc, 1990).
Stepwise multiple regression analysis revealed the independent predictors of BMI based on the variables linear relation to the dependent variable. P b 0.1 was used as the level of rejection from the model and the subjects were coded 0, 1 and 2 for AA, AT and TT genotypes and 0 and 1 for male and female, respectively. Age was also included in the analysis. The appropriateness of the resultant regression models was judged from the Durbin ± Watson statistic (testing for serial correlation of adjacent error terms), and partial plots of the residuals. The tolerance and variance in¯ation factors were taken as measures of collinearity. Low tolerance and high variance in¯ation factors are signs of collinearity, indicating that a variable should not be included in the model.
Results
The Chinese subjects with any aspect of the metabolic syndrome had increased adiposity, a higher blood pressure, an adverse atherogenic lipid pro®le (lower HDL-cholesterol and a higher total and LDL-cholesterol and triglycerides) and increased FPG compared to the control population ( Table 1 ). The b3-adrenergic receptor gene Trp64Arg polymorphism allele and genotype distributions in the various study groups are described in Table 2 . The prevalence of the mutant A allele and AA genotype were 12.7% and 1.7%, respectively in the whole population of 802. The genotype frequency distributions of this polymorphism were in Hardy ± Weinberg equilibrium in each of the study groups examined and in the overall population. The genotype distribution was similar in those Chinese to Japanese, Indian, Samoans, Hispanic and Black American groups. However, in Caucasians, the Arg allele was slightly, but not signi®cantly, lower. 27, 28 However, the Arg allele frequency is higher in American Pima Indians. 11 No differences were observed in the genotype and allele frequency distributions between the control group and the nonoverlapping groups with GIT, hypertension or dyslipidaemia alone or in combination (Table 2) . Furthermore, the overlapping groups, including the obese group, also did not differ in genotype or allele frequency from the controls.
Due to the relatively low frequency of the A allele found in our Chinese population and hence the low frequency of the AA genotype, subjects from all groups with AA or AT genotypes were combined and their biochemical and anthropometric parameters compared to those with the TT genotype ( Table 1) . Subjects carrying the A allele were slightly younger with a greater proportion of males, although these differences were not signi®cant. Fasting plasma HDLcholesterol concentrations were lower in the A allele carriers than those with the TT genotype. Triglyceride concentrations tended to be higher in the ATaAA group, but this was not signi®cant and total and LDLcholesterol concentrations were the same in both groups. BMI was signi®cantly higher in the subjects carrying the A allele, although the classical markers of android adiposity (waist circumference and WHR) were not different between the genotypes. When this relationship was further investigated using analysis of variance, the signi®cant relationships between the A allele and BMI was maintained. These markers consistently and signi®cantly increased with increasing proportions of the A allele. For example, the mean BMI were 28.8, 27.9 and 26.6 kgam 2 for the AA, AT and TT genotypes, respectively (P 0.001).
In the whole population, the genotypes correlated with these parameters both before and after adjustment for age and gender. The relationships were also similar whether the genotypes carrying the A allele were combined or not. The partial correlation coef®-cient and signi®cance values for the BMI, after adjustment for age and gender, were À0.13 and P 0.007. Stepwise multiple regression analysis, as described in the methods and including age and gender, showed that only the b 3 -adrenergic receptor Trp64Arg polymorphism genotype was an independent predictor of BMI (BMI À0.63Âb 3 AR genotype 25.8, P 0.038 for the genotype), with age and gender excluded from the equation.
When the genotype frequencies of those subjects in the upper (range 26.0 ± 41.7 kgam 2 ) and lower (range 14.2 ± 22.7 kgam 2 ) tertiles of BMI were examined, there was a non-signi®cant difference of 13.0% (56.5% vs 43.5%, respectively) in the frequency of the combined ATaAA genotypes (w 2 2.7, P 0.099).
When the population was divided into the various overlapping and non-overlapping study groups with speci®c aspects of the metabolic syndrome, namely GIT, hypertension and dyslipidaemia, correlations between the b 3 -adrenergic receptor gene Trp64Arg polymorphism and BMI remained with the A allele carriers having the higher BMI, especially in the hypertensive groups (Table 3) . There was no association between the genotypes and BMI in the control group. Number (%); groups compared with the control group; HT, hypertension; GIT, glucose intolerance; DL, dyslipidaemia. The genotype and allele frequencies are not different in any of the groups. 
Discussion
Adoption of modern Westernized lifestyles with high calorie and fat diets and limited physical activity has led to rapidly increasing prevalence of the metabolic syndrome in those Asian countries experiencing favourable socio-economic changes. 22 Chinese subjects exhibiting various aspects of the metabolic syndrome, had increased adiposity, particularly central, elevated blood pressures, adverse atherogenic lipid pro®les and reduced glucose tolerance when compared to control populations both in this study (Tables 1 and 2 ) and the published work of others from Hong Kong. 2 Within a population, genetic factors may determine those individuals predisposed to develop the various components of the metabolic syndrome. 29, 30 The b 3 -adrenergic receptor gene Trp64Arg polymorphism is one such genetic factor that has been reported to modulate metabolism. 8, 9 The rare A allele has been associated with a predisposition to develop aspects of the metabolic syndrome such as type 2 diabetes or obesity. 8 ± 10,15 However, previous studies have only examined groups with a single component of the metabolic syndrome in isolation. Furthermore, despite the Chinese belonging to the largest ethnic group, there are only limited data available describing the relationship between the polymorphism and metabolic parameters. 27 In the present study we have investigated the role of this polymorphism in the metabolic syndrome as a whole, as well as examining its possible involvement in subgroups to explore for speci®c effects.
In these Hong Kong Chinese subjects, the polymorphism was signi®cantly associated with BMI. The relationship between this mutation and BMI has been reported in Chinese type 2 diabetics 27 and other major ethnic groups, including Caucasians, 31,32 Blacks 14 and Japanese, 9, 15 in which the reported genotype frequencies are similar to those in our study. The dosedependent relationship between the A allele and the anthropometric markers, as well as the maintenance of this relationship in nearly all the subgroups included in these analyses, supports a contributory role for this polymorphism or a closely linked genetic factor in the modulation of obesity. Although no frequency differences in the genotype distribution were observed between the control and obese populations, there was a tendency for the frequency of the combination of AA and AT genotypes to be higher in association with increasing tertiles of BMI. Thus this gene may play a small, but signi®cant, role in determining BMI as indicated by approximately 2% (r À0.13) of the variance (r 2 ) in the BMI being accounted for by the gene in our whole population. Furthermore, stepwise multiple regression suggests that the b 3 -adrenergic receptor Trp64Arg polymorphism is an independent predictor of BMI. Our study is in agreement with a recent publication in Northern Chinese, that reported the mutation to be signi®cantly associated with BMI in type 2 diabetic subjects. 27 Furthermore, other groups have reported similar associations between this polymorphism and obesity in Japanese populations. 9, 15 In addition to obesity, we found evidence to support the involvement of this gene polymorphism in modulating lipid pro®les with the A allele being associated with reduced fasting plasma HDL-cholesterol levels. A relationship between this polymorphism and lipid metabolism has been reported in a Japanese population, but in association with decreased serum triglyceride concentrations. 15 However, their work does support our ®ndings associating the A allele with increased obesity, in particular with visceral obesity as de®ned by computerized tomography scanning at the level of the umbilicus. Their conclusions rely only on the difference between the homozygote genotypes, of which there were only nine AA homozygotes, because the AT heterozygotes had similar triglyceride levels to those with the TT genotype. The authors proposed that, contrary to the usual association between hypertriglyceridaemia and visceral obesity, this mutation was associated with a form of visceral obesity that presents with decreased lipolysis. Although we found no signi®cant difference in triglyceride levels between the genotypes in our Chinese subjects, our data supports the more conventional relationship between obesity and decreased HDLcholesterol. More in keeping with our ®ndings, another study in young healthy Danes reported three subjects out of 380 who were homozygous for the AA genotype and had higher triglycerides and LDL-cholesterol than the AT or TT genotypes. 32 A common ®nding in other studies has been that the A allele was signi®cantly associated with an earlier age of onset of diabetes. 8, 11, 12 However, in the present study, although the age at diagnosis of type 2 diabetes in patients with the A allele was on average 4.1 y earlier than in patients with the TT genotype, age of diagnosis did not reach signi®cance due to the large variations within groups. However, subjects with type 2 diabetes are often asymptomatic initially and the age of diagnosis may not accurately re¯ect the age of onset of the disease. As such, unrecognized selection biases may be responsible for identifying differences in this parameter in some studies, but not others. There was also no difference in the genotype frequencies between those subjects with GIT and the control population. This latter ®nding is in agreement with the majority of other studies that have investigated this gene in diabetic populations. 8, 11, 18, 33, 34 Not all groups have found the associations between this polymorphism and components of the metabolic syndrome described by us and others in Caucasians, Blacks, Hispanics, Orientals or Pima Indians, 9, 11, 14, 15, 31, 32 with some studies in Caucasians and Japanese reporting negative ®ndings. 16 ± 19 Although there is clearly a controversy and some of the positive associations may be due to chance, in most of the positive reports, as in our study, the b b 3 -adrenergic receptor polymorphism and obesity GN Thomas et al polymorphism tends to show a quantitative or incremental relationship between the genotypes and the associated metabolic parameters. Furthermore, the mutant A allele is consistently associated with metabolic and cardiovascular risk factors in a wide range of subgroup analyses. Whilst prospective and functional studies are required to elucidate these relationships more clearly, it is plausible that this gene may interact with other genetic and environmental factors to contribute to the modulation of metabolic parameters and obesity. Its effects may be particularly noticeable in populations undergoing rapid changes in lifestyles.
